20 Nov 2013, BioSpectrum Bureau , BioSpectrum
Singapore: US-based Intrexon, a synthetic biology company, has appointed Dr Peter Seufer-Wasserthal as VP, business development for Europe and Asia and Ms Dana Di Ferdinando as chief information officer.
Intrexon chief operating officer Mr Krish Krishnan, said, "We are excited to have Ms Di Ferdinando and Dr Seufer-Wasserthal join Intrexon at this stage of our growth. Dana will lead development of the next generation of Intrexon's proprietary technologies, particularly UltraVector, an industry-leading software platform that enables our collaborators to design, test, and produce complex biological solutions with the goal of generating superior commercial products."
He further said, "Peter will expand Intrexon's presence even further into Europe and Asia, growing our international relationships to establish additional collaborations abroad. I am confident that their respective professional experiences and insights will be a tremendous asset to Intrexon."
Dr Seufer-Wasserthal will broaden Intrexon's European and Asian market sectors in food, health, energy and environment, establishing exclusive channel collaborations and other R&D opportunities. Prior to joining Intrexon, Dr Seufer-Wasserthal was senior VP of pharmaceuticals at Codexis, responsible for closing numerous licensing, research and supply agreements, and adapting IP strategy to increase account penetration.
Ms Di Ferdinando brings to Intrexon more than 25 years of professional experience in the management, engineering, analysis and implementation of integrated solutions for life sciences and technology companies. Most recently, she was CIO at Arena Pharmaceuticals, where she managed IT functions and oversaw enterprise business technology initiatives and application development efforts at Arena's US, European and Asian locations. Prior to Arena, Ms Di Ferdinando worked for major consulting and analytics companies Deloitte & Touche and Science Applications International Corporation (SAIC).